Longer local retention of adoptively transferred T-LAK cells correlates with lesser adhesion molecule expression than NK-LAK cells
Open Access
- 1 April 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 100 (1) , 13-20
- https://doi.org/10.1111/j.1365-2249.1995.tb03597.x
Abstract
The local retention of adoptively transferred lymphokine (IL‐2)‐activated killer (LAK) cells was examined in 11 patients with head and neck carcinoma. Unseparated lymphocytes, T and natural killer (NK) cells isolated from patients were cultured with IL‐2 for 7 days, labelled with 99mTc‐HMPAO, and immediately injected back into the respective donors via the superficial temporal artery or locally into the tumour tissue. The injected LAK cells were periodically traced using a gamma camera, and the LAK cell retention rate was calculated from the radioactivity. One hour after the injection, about 70% of the locally infiltrated LAK cells remained in the tumour tissue, while about half of the LAK cells transferred via the regional artery were dislodged from the tissue. LAK cells induced from T cells (T‐LAK) were retained in the tissue for a longer time than LAK cells induced from NK cells (NK‐LAK). T‐LAK were less chemotactic and less adherent to human umbilical vein endothelial cells (EC), and showed lesser migration through EC. Flow cytometric analysis revealed higher expression of CD11a, CD11b, CD18 and CD49d on NK‐LAK compared with T‐LAK. MoAbs against these adhesion molecules suppressed adhesion and migration of LAK cells. These results indicate that the rapid disappearance of NK‐LAK from the tissue is associated with their greater chemotactic and adhesive as well as migratory activities depending on differing expression of adhesion molecules.Keywords
This publication has 42 references indexed in Scilit:
- Distinct Phenotypic and Functional Characteristics of Human Natural Killer Cells Obtained by Rapid Interleukin 2-Induced Adherence to PlasticCellular Immunology, 1993
- Lymphocyte-Endothelial Cell Adhesion Molecules at the Primary Tumor Site in Human Lung and Renal Cell CarcinomasJNCI Journal of the National Cancer Institute, 1993
- Expression of the adhesion molecules ICAM‐1 and ICAM‐2 on tumor cell lines does not correlate with their susceptibility to natural killer cell‐mediated cytolysis: evidence for additional ligands for effector cell β2 integrinsEuropean Journal of Immunology, 1992
- Enhancement of Lymphokine-Activated Killer Activity Induction In Vitro by Interleukin-1 Administered in Patients with Urological MalignanciesJournal of Immunotherapy, 1992
- Adhesion Molecules on Murine Lymphokine‐activated Killer Cells Responsible for Target Cell Killing: A Role of CD2Japanese Journal of Cancer Research, 1991
- Phase II Trial of High-Dose Interleukin-2 and Lymphokine-Activated Killer Cells in Hodgkin??s Disease and Non-Hodgkin??s LymphomJournal of Immunotherapy, 1991
- In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitroCellular Immunology, 1991
- TNF-α and IFN-γ reverse IL-4 inhibition of lymphokine-activated killer cell functionCellular Immunology, 1990
- Functional interactions of IL2 and TNF in the differentiation of LGL into lak effectorsInternational Journal of Cancer, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987